Recurrent indolent NHL: new strategies for treatment.
Amen
Keightley
K
D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D016903:Drug Monitoring; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D009367:Neoplasm Staging; D024802:Nurse's Role; D009859:Oncology Nursing; D010353:Patient Education as Topic; D011379:Prognosis; D011788:Quality of Life; D012008:Recurrence; D012307:Risk Factors; D015996:Survival Rate